Morgan E Roberts, Jacquelyn P Crail, Megan M Laffoon, William G Fernandez, Michael A Menze, Mary E Konkle
Index: Biochemistry 52(50) , 8969-71, (2013)
Full Text: HTML
MitoNEET is a protein that was identified as a drug target for diabetes, but its cellular function as well as its role in diabetes remains elusive. Protein pull-down experiments identified glutamate dehydrogenase 1 (GDH1) as a potential binding partner. GDH1 is a key metabolic enzyme with emerging roles in insulin regulation. MitoNEET forms a covalent complex with GDH1 through disulfide bond formation and acts as an activator. Proteomic analysis identified the specific cysteine residues that participate in the disulfide bond. This is the first report that effectively links mitoNEET to activation of the insulin regulator GDH1.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
gldh
CAS:9029-12-3 |
|
High-Throughput Assay Development for Cystine-Glutamate Anti...
2015-01-01 [PLoS ONE 10 , e0127785, (2015)] |
|
Extensive Charge Reduction and Dissociation of Intact Protei...
2015-07-01 [J. Am. Soc. Mass Spectrom. 26 , 1068-76, (2015)] |
|
Glutamine supports pancreatic cancer growth through a KRAS-r...
2013-04-04 [Nature 496(7443) , 101-5, (2013)] |
|
Synapse formation and maintenance by C1q family proteins: a ...
2010-07-01 [Eur. J. Neurosci. 32(2) , 191-7, (2010)] |
|
Mutations in human GLUD2 glutamate dehydrogenase affecting b...
2009-05-01 [J. Neurochem. 109 Suppl 1 , 167-73, (2009)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
